BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35488172)

  • 1. ASO Author Reflections: An Alternative to Sentinel-Node Biopsy? Preoperative Sonographic Prediction of Limited Axillary Disease in Breast Cancer Patients Meeting the Z0011 Criteria.
    Radosa JC; Solomayer EF; Deeken M; Minko P; Zimmermann JSM; Kaya AC; Radosa MP; Stotz L; Huwer S; Müller C; Karsten MM; Wagenpfeil G; Radosa CG
    Ann Surg Oncol; 2022 Aug; 29(8):4773-4774. PubMed ID: 35488172
    [No Abstract]   [Full Text] [Related]  

  • 2. Preoperative Sonographic Prediction of Limited Axillary Disease in Patients with Primary Breast Cancer Meeting the Z0011 Criteria: an Alternative to Sentinel Node Biopsy?
    Radosa JC; Solomayer EF; Deeken M; Minko P; Zimmermann JSM; Kaya AC; Radosa MP; Stotz L; Huwer S; Müller C; Karsten MM; Wagenpfeil G; Radosa CG
    Ann Surg Oncol; 2022 Aug; 29(8):4764-4772. PubMed ID: 35486266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASO Author Reflections: Objective Outcome Measure of Upper Limb Function Following Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy.
    Che Bakri NA; Kwasnicki RM; Giannas E; Tenang L; Khan N; Moenig C; Imam Z; Dhillon K; Ashrafian H; Darzi A; Leff DR
    Ann Surg Oncol; 2023 Nov; 30(12):7133-7134. PubMed ID: 37482598
    [No Abstract]   [Full Text] [Related]  

  • 4. Preoperative predictors of high and low axillary nodal burden in Z0011 eligible breast cancer patients with a positive lymph node needle biopsy result.
    Lim GH; Upadhyaya VS; Acosta HA; Lim JMA; Allen JC; Leong LCH
    Eur J Surg Oncol; 2018 Jul; 44(7):945-950. PubMed ID: 29705286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASO Author Reflections: Future View: A Recent Scientific Contribution Towards a Staging Revision of Contralateral Axillary Lymph Node Metastases from Breast Cancer.
    Magnoni F; Intra M
    Ann Surg Oncol; 2020 Oct; 27(11):4500-4501. PubMed ID: 32430751
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: Omission of Axillary Lymph Node Dissection for Breast Cancer Patients with Residual N1 Nodal Disease Following Neoadjuvant Chemotherapy: Not Ready for Primetime?
    Almahariq MF; Chen PY; Dekhne N; Dilworth JT
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):869-870. PubMed ID: 32737699
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: Standardizing Pathology Examination of Sentinel Lymph Nodes in Invasive Lobular Carcinoma: Less Is More.
    Hieken TJ; Solanki MH
    Ann Surg Oncol; 2022 Oct; 29(10):6466-6467. PubMed ID: 35930110
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: Refining Risk Assessment in Node-Positive Breast Cancer Patients Eligible for Sentinel Lymph Node Biopsy Alone.
    Mamtani A; Morrow M
    Ann Surg Oncol; 2020 Oct; 27(10):3593-3594. PubMed ID: 32440719
    [No Abstract]   [Full Text] [Related]  

  • 9. Axillary lymph node dissection is not obligatory in breast cancer patients with biopsy-proven axillary lymph node metastasis.
    Yoo TK; Kang BJ; Kim SH; Song BJ; Ahn J; Park WC; Chae BJ
    Breast Cancer Res Treat; 2020 Jun; 181(2):403-409. PubMed ID: 32328848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of axillary lymph node ultrasound and large core biopsy in the preoperative assessment of patients selected for sentinel node biopsy.
    Nori J; Bazzocchi M; Boeri C; Vanzi E; Nori Bufalini F; Mangialavori G; Distante V; Masi A; Simoncini R; Londero V
    Radiol Med; 2005 Apr; 109(4):330-44. PubMed ID: 15883518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ASO Author Reflections: Axillary Staging in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy-Beyond Clinical Trials.
    Montagna G; Morrow M
    Ann Surg Oncol; 2020 Oct; 27(11):4523-4524. PubMed ID: 32500341
    [No Abstract]   [Full Text] [Related]  

  • 12. No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS]: protocol of a prospective randomized clinical trial.
    Jung JG; Ahn SH; Lee S; Kim EK; Ryu JM; Park S; Lim W; Jung YS; Chung IY; Jeong J; Chang JH; Shin KH; Chang JM; Moon WK; Han W
    BMC Cancer; 2022 Feb; 22(1):189. PubMed ID: 35184724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer patients with extra-axillary sentinel nodes only may be spared axillary lymph node dissection.
    van der Ploeg IM; Tanis PJ; Valdés Olmos RA; Kroon BB; Rutgers EJ; Nieweg OE
    Ann Surg Oncol; 2008 Nov; 15(11):3239-43. PubMed ID: 18773244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing single or dual tracing modality on sentinel lymph node biopsy from patients who plan to omitting axillary lymph node dissection referring to the criteria of Z0011 trial: a retrospective study.
    Xu Y; Wu H; Zhang W; Shen Y; Jiang Y; Meng L
    Updates Surg; 2022 Jun; 74(3):1073-1078. PubMed ID: 35389176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher axillary lymph node metastasis burden in breast cancer patients with positive preoperative node biopsy: may not be appropriate to receive sentinel lymph node biopsy in the post-ACOSOG Z0011 trial era.
    Liang Y; Chen X; Tong Y; Zhan W; Zhu Y; Wu J; Huang O; He J; Zhu L; Li Y; Chen W; Shen K
    World J Surg Oncol; 2019 Feb; 17(1):37. PubMed ID: 30786903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-sentinel axillary tumor burden applying the ACOSOG Z0011 eligibility criteria to a large routine cohort.
    Riedel F; Heil J; Feißt M; Rezai M; Moderow M; Sohn C; Schütz F; Golatta M; Hennigs A
    Breast Cancer Res Treat; 2019 Sep; 177(2):457-467. PubMed ID: 31236814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a role for sentinel node biopsy in the pre-operative ultrasound positive axilla?
    Ahmed M; Jozsa F; Douek M
    Breast Cancer Res Treat; 2017 Sep; 165(2):225-228. PubMed ID: 28597050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASO Author Reflections: Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy.
    Verreck E; van Steenhoven J; van Dalen T
    Ann Surg Oncol; 2023 Sep; 30(9):5633-5634. PubMed ID: 37378845
    [No Abstract]   [Full Text] [Related]  

  • 19. Is axillary lymph node clearance required in node-positive breast cancer?
    Bundred NJ; Barnes NL; Rutgers E; Donker M
    Nat Rev Clin Oncol; 2015 Jan; 12(1):55-61. PubMed ID: 25367714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of the axilla: has Z0011 had an impact?
    Joyce DP; Lowery AJ; McGrath-Soo LB; Downey E; Kelly L; O'Donoghue GT; Barry M; Hill AD
    Ir J Med Sci; 2016 Feb; 185(1):145-9. PubMed ID: 25595827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.